SRM Institute of Science and Technology, India
Author Profile
Early Academic Pursuits:
Dr. S. Sundaresan embarked on his academic journey with a strong foundation in Biochemistry, beginning with a Bachelor's degree from Annamalai University. He continued his pursuit of knowledge with a Master's degree and a subsequent M. Phil. in Biochemistry from the University of Madras. His academic journey culminated in a Ph.D. in Biochemistry from the University of Madras, where he laid the groundwork for his future endeavors in the field.
Professional Endeavors:
His professional journey commenced with a significant role as a Research Scientist at Annamalai University, where he contributed to a project sponsored by the National Institute of Health, USA. Subsequently, he held positions at various esteemed institutions, including Bharat Scans Pvt Ltd, IIBAT, and SRM MCH & RC, gaining diverse laboratory experience in Clinical Biochemistry and Biochemistry divisions. His roles included managing sophisticated laboratory equipment and supervising research activities.
Contributions and Research Focus:
His research interests primarily revolve around cancer chemoprevention, cancer immunotherapy, and tumor marker detection. Noteworthy contributions include the development of Andro/Evo-albumin nanoparticles loaded into polycaprolactone scaffolds, the study of tumor markers and gene expressions in hepatocellular carcinoma (HCC), and investigating the efficacy of various compounds for cancer prevention and treatment. His current focus lies in exploring the impact of probiotics on alleviating intestinal toxicity during cancer therapy.
Accolades and Recognition:
Throughout his illustrious career, He has garnered numerous awards and fellowships, underscoring his significant contributions to the field of Biochemistry and Cancer Research. Notable accolades include the Research Scientist Fellowship from NIH US Project, Young Scientist DST-Fast Track Award from DST New Delhi, and several research appreciation awards from SRM University. His exemplary research has also been recognized with paper presentation awards and medals.
Impact and Influence:
His research has had a profound impact on the understanding and treatment of cancer. His studies on cancer chemoprevention, tumor markers, and novel treatment modalities have expanded the horizons of cancer research, paving the way for innovative therapeutic strategies. Additionally, his mentorship of Ph.D. students and involvement in scholarly activities have nurtured the next generation of researchers, further extending his influence in the scientific community.
Legacy and Future Contributions:
His legacy is marked by his relentless pursuit of excellence in scientific research and his dedication to advancing the field of Biochemistry and Cancer Biology. As he continues his journey, he aims to further his investigations into cancer prevention, immunotherapy, and the therapeutic potential of probiotics. Through his ongoing efforts, Dr. Sundaresan seeks to leave a lasting impact on cancer treatment and patient care, shaping the future of oncology research.
A total of 496 citations for his publications, demonstrating the impact and recognition of his research within the academic community.
- Citations 496
- h-index 11
- i10-index 12
Notable Publications
S-allylcysteine inhibits circulatory lipid peroxidation and promotes antioxidants in N-nitrosodiethylamine-induced carcinogenesis
S Sundaresan, P Subramanian
[105] 2003
Prevalence of anemia in the school children of Kattankulathur, Tamil Nadu, India
B Sudhagandhi, S Sundaresan, WE William, A Prema
[90] 2011
Prevention of N-nitrosodiethylamine-induced hepatocarcinogenesis by S-allylcysteine
S Sundaresan, P Subramanian
[54] 2008
The relationship between histological differentiation and disease recurrence of primary oral squamous cell carcinoma
R Padma, A Kalaivani, S Sundaresan, P Sathish
[51] 2017
Hepatoprotective activity of Boerhavia diffusa L.(Nyctaginaceae) against ibuprofen induced hepatotoxicity in wistar albino rats
A Jayavelu, A Natarajan, S Sundaresan, K Devi, B Senthilkumar
[28] 2013
Antiproliferative and anti-inflammatory properties of diindolylmethane and lupeol against N-butyl-N-(4-hydroxybutyl) nitrosamine induced bladder carcinogenesis …
B Prabhu, D Balakrishnan, S Sundaresan
[24] 2016
Evaluation of chemopreventive potential of garlic extract on N-nitrosodiethylamine-induced hepatocarcinoma in rats
S Sundaresan, P Subramanian
[21] 2002
Synergistic anti-carcinogenic effect of interferon-β with cisplatin on human breast adenocarcinoma MDA MB231 cells
P Ethiraj, K Veerappan, B Doraisami, S Sivapatham
[14] 2014
Squamous cell carcinoma of buccal mucosa: Prevalence of clinicopathological pattern and its implications for treatment
R Padma, S Paulraj, S Sundaresan
[13] 2017
Interferon β improves the efficacy of low dose cisplatin by inhibiting NF-κB/p-Akt signaling on HeLa cells
P Ethiraj, K Veerappan, S Samuel, S Sivapatham
[13] 2016